SALVADORI, Severo
 Distribuzione geografica
Continente #
NA - Nord America 21.481
AS - Asia 8.876
EU - Europa 5.659
SA - Sud America 1.371
AF - Africa 127
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 37.536
Nazione #
US - Stati Uniti d'America 21.171
SG - Singapore 3.497
CN - Cina 2.708
UA - Ucraina 1.307
DE - Germania 1.274
BR - Brasile 1.152
HK - Hong Kong 907
TR - Turchia 855
GB - Regno Unito 759
IT - Italia 698
FI - Finlandia 460
VN - Vietnam 429
SE - Svezia 353
RU - Federazione Russa 265
MX - Messico 143
FR - Francia 142
CA - Canada 141
PL - Polonia 104
IN - India 91
BE - Belgio 77
AR - Argentina 74
JP - Giappone 69
ZA - Sudafrica 62
BD - Bangladesh 56
ID - Indonesia 50
NL - Olanda 47
ES - Italia 45
EC - Ecuador 36
CO - Colombia 35
IQ - Iraq 32
LT - Lituania 32
AT - Austria 21
PK - Pakistan 21
IR - Iran 20
UZ - Uzbekistan 20
KR - Corea 19
MA - Marocco 18
CL - Cile 17
CZ - Repubblica Ceca 17
PY - Paraguay 16
VE - Venezuela 15
IL - Israele 14
AE - Emirati Arabi Uniti 13
PE - Perù 13
RO - Romania 13
SA - Arabia Saudita 11
TN - Tunisia 11
EG - Egitto 9
KE - Kenya 9
UY - Uruguay 9
CH - Svizzera 8
JO - Giordania 8
NP - Nepal 8
IE - Irlanda 6
AU - Australia 5
AZ - Azerbaigian 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EU - Europa 5
LB - Libano 5
NZ - Nuova Zelanda 5
PH - Filippine 5
BG - Bulgaria 4
HN - Honduras 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BO - Bolivia 3
DK - Danimarca 3
GT - Guatemala 3
HR - Croazia 3
KZ - Kazakistan 3
NO - Norvegia 3
PA - Panama 3
SN - Senegal 3
AM - Armenia 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MM - Myanmar 2
MY - Malesia 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
EE - Estonia 1
Totale 37.514
Città #
Fairfield 2.364
Woodbridge 2.349
Singapore 2.040
Ashburn 1.887
Houston 1.587
Jacksonville 1.429
Ann Arbor 1.248
Chandler 1.102
Seattle 912
Beijing 907
Hong Kong 904
Wilmington 847
Santa Clara 839
Cambridge 789
Izmir 437
Nanjing 415
Dallas 345
Munich 310
Los Angeles 287
Princeton 276
San Diego 233
New York 205
Boardman 196
Dearborn 196
Milan 186
Ho Chi Minh City 153
Ferrara 151
Nanchang 121
São Paulo 119
Falkenstein 117
Helsinki 116
Shenyang 116
Hefei 110
Shanghai 101
Mexico City 97
Warsaw 95
Hanoi 91
Addison 89
Falls Church 81
Turku 78
London 77
San Mateo 75
Brussels 72
Hebei 72
Brooklyn 68
Tianjin 68
Tokyo 68
Auburn Hills 65
Jiaxing 63
Bremen 62
Jinan 62
Changsha 61
Chicago 55
Mountain View 49
Orem 49
Buffalo 48
Kunming 47
Moscow 45
Denver 42
Montreal 42
San Francisco 42
Redwood City 41
Frankfurt am Main 40
Washington 40
Zhengzhou 39
Philadelphia 38
Poplar 38
Stockholm 38
Toronto 38
Johannesburg 37
Ningbo 35
Norwalk 35
Atlanta 34
Rio de Janeiro 34
The Dalles 34
Phoenix 33
Boston 32
Belo Horizonte 30
Columbus 28
Chennai 27
Guangzhou 27
Bologna 25
Manchester 25
Tappahannock 24
Des Moines 22
Mcallen 22
Orange 21
Charlotte 20
Jakarta 20
Indiana 19
Biên Hòa 17
Curitiba 17
Haiphong 17
Montréal 17
Mumbai 17
Tashkent 17
Ankara 16
Augusta 16
Da Nang 16
Dhaka 16
Totale 26.219
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 347
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 292
A cyclic peptide T analogue with high chemotactic activity 263
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 262
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 260
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 254
A new selective antagonist of the nociceptin receptor 236
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 235
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 221
A new ligand for the urotensin II receptor 218
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 213
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 212
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 209
2-Bromoamides as Synthons for Pseudopeptides Containing Aminodicarboxy Units 207
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 206
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 206
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 205
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 205
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 205
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 205
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 205
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 201
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 200
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 197
Dermorphin inhibits spinal nociceptive flexion reflex in humans 194
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 193
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 193
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 193
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 193
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 190
Physicochemical stability of cabazitaxel and docetaxel solutions 190
Pharmacological characterization of tachykinin tetrabranched derivatives 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 189
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 188
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 188
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 186
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 186
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 185
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 183
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 183
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 181
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 179
Pharmacological characterization of nociceptin receptor: an in vitro study 179
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. 178
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 178
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 177
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 176
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 176
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 175
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 174
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 174
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 173
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 173
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 171
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 170
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 170
Neuropeptide S receptor ligands: a patent review (2005-2016) 170
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 169
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 169
Design of d-opioid peptide antagonists for emerging drug applications 169
Structure-activity study at positions 3 and 4 of human neuropeptide S. 168
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 167
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 165
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 165
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 165
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 164
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 164
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 163
Critical role for prokineticin 2 in CNS autoimmunity 162
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 161
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 161
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 159
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 159
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 159
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 159
Structure–activity relationships of cyclic and linear peptide T analogues 158
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores 157
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 157
Synthetic Approach to non-Isosteric Peptidomimetics Related to Human Endothelin 156
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation 156
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 155
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 155
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 155
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 154
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 153
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 152
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 152
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 152
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 152
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 152
Somatostatin Inhibits the Dermorphin-Stimulated Thyrotropin Release in Man 151
Characterization of N,N(Me)(2)-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist 150
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands 149
Synthesis and biological activity of carboxyl terminally extended dermorphins 149
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 148
Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders. 148
Role of benzimidazole (Bid) in the d-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH2-Bid (UFP-502) 148
Structure-activity relationship study on human urotensin II 148
Opioid receptor selectivity alteration by single residue replacement: Synthesis and activity profile of [Dmt]deltorphin B 147
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 147
Totale 18.211
Categoria #
all - tutte 174.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.988
Totale 177.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.028 0 0 0 0 0 366 112 408 84 417 470 171
2021/20222.994 126 290 230 211 230 135 136 170 114 228 224 900
2022/20232.733 297 96 90 335 463 380 148 272 388 16 143 105
2023/20241.291 150 183 94 32 103 233 51 82 17 22 32 292
2024/20255.005 141 106 410 141 637 458 156 346 682 512 749 667
2025/20268.494 1.509 666 1.429 2.046 2.032 812 0 0 0 0 0 0
Totale 37.796